<DOC>
	<DOCNO>NCT02769923</DOCNO>
	<brief_summary>The investigator assess usability immune response follow fractional dose inactivate polio virus vaccine ( fIPV ) administration two novel intradermal adapter ( ID adapter West Pharmaceutical service Inc. Star Intradermal syringe Star Syringe Ltd. ) compare response one achieve fIPV administer traditional BCG needle syringe .</brief_summary>
	<brief_title>ID Administration fIPV Using Intradermal Adapters vs. BCG Syringe</brief_title>
	<detailed_description>The study conduct follow two phase . 1 . Phase I : Ergonometric evaluation serology : Phase I base community base randomize control trial three arm . List household child age 6-12 month retrieve demographic surveillance system . Train CHWs visit household provide relevant information regard study parent . The child parent provide write informed consent screen eligibility enrol study . The child accompany parents/guardians carry primary health center Dept . pediatrics child health , AKU . Baseline 3ml blood collect train study phlebotomist EDT tubes transport infectious disease research laboratory ( IDRL ) AKU . A sample 450 child randomize use sealed envelope one three study arm . Arm 1 , receive fIPV use WestPharma device , arm 2 receive fIPV use Star ID syringe arm 3 receive fIPV use BCG syringe . The child observe 30 minute adverse event . The research Assistants interview parent fill socio-demographic questionnaire vaccinator fill ergonometric injection quality questionnaire . The child follow 28 day ( 4 week ) enrollment another 3ml blood collect trained phlebotomist . Details visit record follow-up questionnaire . Both baseline endline blood sample test immune response polio virus 1,2 3 . 2 . Phase II : Pilot campaign demonstration : In phase , investigator conduct door door campaign high risk community provide fIPV use either WestPharma device Star ID syringe BCG needle syringe . In campaign , child le 5 year age , live study area whose parent provide verbal consent receive intradermal injection fIPV use three device train research assistant . This one day campaign coordination provincial polio emergency operation center ( EOC ) . About 300 child receive fIPV use three device .</detailed_description>
	<criteria>Children age 612 month live four periurban slum Bin Qasim Town , Karachi ( Rehri Goth , Bhains Colony , Ali Akber Shah , Ibrahim Hydri ) . Child find acutely ill time enrolment require emergent medical care/hospitalization . Refusal blood test . Any contraindication ID injection . A diagnosis suspicion immunodeficiency disorder ( either participant member immediate family . e.g . several early infant death , household member chemotherapy ) render newborn ineligible study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>WestPharma ID-adapter</keyword>
	<keyword>Star ID syringe</keyword>
	<keyword>BCG needle syringe</keyword>
	<keyword>fractional dose IPV</keyword>
	<keyword>fIPV</keyword>
	<keyword>polio</keyword>
	<keyword>Polio Endgame</keyword>
	<keyword>IPV</keyword>
</DOC>